Skip to content
Riskpilot
← Back to search
Sign in
Get full access
UroMedical PS AB
AB
Active
Org 5565166302
Drottninggatan 97, 113 60
Stockholm
Medical specialists activities
·
NACE 8622
Est. 1995 · 30 years old
14 employees
Monitor
Share
Sweden
/
Companies
/
Medical specialists activities
/
UroMedical PS AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
ER
Erik Rönnblad
Chief Executive Officer
Chief Executive Officer
2026
KK
Karin Kristina Eriksson
Chief Auditor
Chief Auditor
2020
AU
Anna Ulrika Hansson
Chief Executive Officer
Chief Executive Officer
2024
Former (2)
AG
Anders Gunnar Pålhed
Audit
Audit
2020 – 2020
ML
Marie Louise Birgitta Agelin
External Signatory
External Signatory
2020 – 2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
JW
Jan-Olof Wiklund
Deputy Board Member
Deputy Board Member
2024
JK
Jonathan Kimber
Chairman
Chairman
2025
Former (12)
TH
Thomas Haugen Skorpen
Board of Directors
Board of Directors
2023 – 2023
ØB
Øyvind Bakke
Board of Directors
Board of Directors
2023 – 2024
KL
Kurt Lennart Robertsson
Board of Directors
Board of Directors
2020 – 2022
GL
Gard Lauvsnes
Board of Directors
Board of Directors
2020 – 2022
FR
Fred Rosendal Helgesen
Chairman
Chairman
2024 – 2025
KD
Kim Daniel Dahl
Deputy Board Member
Deputy Board Member
2020 – 2020
PB
Patrik Bø Egeland
Chairman
Chairman
2023 – 2023
EL
Eskild Larsen
Chairman
Chairman
2022 – 2023
MH
Morten Henrik Greidung
Chairman
Chairman
2020 – 2022
AM
Anna Maria Kristina Frånlund
Board of Directors
Board of Directors
2022 – 2024
RG
Robert Gelmanovski
Chairman
Chairman
2022 – 2022
KJ
Kurt Jonas Einar Hugosson
Board of Directors
Board of Directors
2024 – 2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
UroMedical BidCo AB
Company
100%
100%
2025
C-Medical Sverige AB
Company
100%
100%
0001
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on UroMedical PS AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network